Abingworth LLP

Holdings History for Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Symbol: PHAT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2022	5.3%	0%	$16,101,889	1,435,106	0		$11.22	Q4 2022
30 Sep 2022	5.4%	0%	$15,901,000	1,435,106	0		$11.08	Q3 2022
30 Jun 2022	3.9%	0%	$12,112,000	1,435,106	0		$8.44	Q2 2022
31 Mar 2022	5.5%	+0.89%	$19,503,000	1,435,106	+231,971	+19%	$13.59	Q1 2022
31 Dec 2021	5.7%	0%	$23,606,000	1,203,135	0		$19.62	Q4 2021
30 Sep 2021	8.7%	0%	$38,512,000	1,203,135	0		$32.01	Q3 2021
30 Jun 2021	13%	0%	$40,726,000	1,203,135	0		$33.85	Q2 2021
31 Mar 2021	16%	0%	$45,057,000	1,203,135	0		$37.45	Q1 2021
31 Dec 2020	14%	0%	$39,956,000	1,203,135	0		$33.21	Q4 2020
30 Sep 2020	9.5%	0%	$44,516,000	1,203,135	0		$37.00	Q3 2020
30 Jun 2020	11%	0%	$39,367,000	1,203,135	0		$32.72	Q2 2020
31 Mar 2020	20%	0%	$30,824,000	1,203,135	0		$25.62	Q1 2020
31 Dec 2019	18%	+18%	$37,430,000	1,203,135	+1,203,135	NEW	$31.11	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.